Loading clinical trials...
Loading clinical trials...
qDSA Blood Flow Measurement in Patients Undergoing Transarterial Embolization (TAE) of the Liver
Conditions
Interventions
qDSA Blood Flow Measurement
Locations
1
United States
UW Hospital and Clinics
Madison, Wisconsin, United States
Start Date
March 13, 2025
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
March 30, 2026
NCT07417397
NCT06642220
NCT06788353
NCT04834674
NCT07315022
NCT07281664
Lead Sponsor
University of Wisconsin, Madison
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions